Taking Zantac Was An Elective Decision Not A Medical Necessity

Doctors are warned to monitor the kidney health of those that have switched from Zantac to PPI drugs like Nexium, Prilosec, and Prevacid

Wednesday, September 23, 2020 - Ranitidine drugs like Zantac which were taken to relieve acid indigestion have been pulled from the market after researchers found highly elevated levels of NDMA, a known carcinogen. Thousands of Zantac users are filing lawsuits across the country accusing Zantac of causing their cancer and Zantac's maker, Sanofi, of failing to warn consumers of the cancer danger. Zantac users are reporting suffering from several types of cancer including cancer of the stomach, bladder, esophagas, colon, prostate, and breast and are seeking guidance from qualified legal professionals. Zantac heartburn stomach cancer attorneys offer a free consultation and no obligation to file a claim.

Ranitidine alternative drug called protein pump inhibitors (PPI)s sold by brand names like Nexium, Prilosec, and Prevacid, are now considered dangerous since there have been reports of causing gradual kidney damage and eventually kidney failure. When H2-blocker drug Zantac was recalled, the FDA recommended patients switch to PPI drugs which have not shown to contain dangerous levels of NDMA. Histamine blocker drugs are used when the stomach produces too much acid. Zantac users should think twice before making the switch, however, because reliable studies indicate PPI drugs could do more harm than good.

According to researchers at Washington University School of Medicine, taking PPI drugs over a long period is linked to kidney damage that is unnoticable until it is too late. Dr. Ziyad Al-Aly, MD, assistant professor of medicine at Washington University School of Medicine conducted a study of 125,000 PPI patients to examine their history of kidney problems and concluded: "Our results indicate kidney problems can develop silently and gradually over time, eroding kidney function and leading to long-term kidney damage or even renal failure. Patients should be cautioned to tell their doctors if they're taking PPIs and only use the drugs when necessary."

It is unsettling to note that most people that have switched to PPI drugs have done so out of convenience and habit more than due to wanting to improve their health. Yet another study indicates that most Zantac or PPI heartburn and acid reflux patients did not need to take either drug. The Guardian reports: "... out of the 15 million Americans prescribed heartburn medications, only one-fourth need them. The vast majority of consumers can stop taking over-the-counter or prescription heartburn drugs without experiencing any adverse effects." Doctors that prescribe or recommend OTC PPI drugs are urged to consider the patient's kidney health and advise them of the risks so they can make an informed decision. Heartburn and acid reflux is easily treated by eating less, eating more healithly, and leading a less-stressful lifestyle, rather than taking a Zantac or Prilosec the moment heartburn discomfort occurs.

Finally, the International Foundation for Gastrointestinal Disorders (GERD) warns patients considering taking PPI drug to consider long term PPI usage could have more adverse health consequences that kidney damage. "Be aware that an increased risk of fractures of the hip, wrist, and spine has been reported in some studies of patients using proton pump inhibitors. The greatest increased risk for these fractures was seen in patients who receive high doses of these medications or use them longer (a year or more)."

More Recent Heartburn MedicineLawsuit News:

• Zantac Cancer Trials Are In Discovery To Begin In October 2022 | 7/19/2022
• Zantac Cancer Lawsuits Could Hinge On The Validity of Ranitidine Testing Methods | 7/11/2022
• Zantac Cancer Bellwether Trials In California Could Set The Stage For A Global Settlement Offer | 7/5/2022
• The FDA Recommended Protein Pump Inhibitor Drugs Like Prilosec And Nexium That May Damage Health More Than Zantac | 6/23/2022
• Truck Drivers, Firefighters, and Police Officers May Have Taken More Zantac Than People In Other Occupations | 6/20/2022
• Scientists Are Expected To Confirm That Ranidine Causes Gastrointestinal Cancer With Slam Dunk Testimony | 6/9/2022
• Scientific Hearings Will Start This September To Interview Zantac Cancer Expert Witnesses | 5/19/2022
• A Whistleblower Scientist Working For A Chinese Company Thinks NDMA Contamination Started In China | 5/12/2022
• Valisure's String Of Stunning Success Casts Doubt On The FDAs Ability To Police The Health Care Market | 5/2/2022
• Zantac Testing Accusations Heat Up With FDA Investigation Of Online Prescription Drug Testing Lab | 4/25/2022
• Study Finds Ranitidine Degrades Into 10,000 Nanograms of NDMA When Introduced To Simulated Stomach Conditions | 4/6/2022
• Potential Zantac Expert Witnesses Are Being Questioned By Zantac Defense Attorneys | 3/31/2022
• The FDA Requires That Drug Companies Regularly Test Ranitidine And Other Drug For NDMA | 3/24/2022
• Update: Where The Zantac Cancer Multidistrict Litigation (MDL) Stands Today | 3/12/2022
• Zantac Cancer Plaintiffs Look To The First Trial In October In Alameda California | 3/11/2022
• Zantac Cancer Plaintiffs Have Until June 30 To Finalize Their Claim | 3/7/2022
• Zantac Bellwether Trials May Focus On Ranitidine Testing Methods That Could Cause NDMA To Accelerate | 3/1/2022
• Valisure LLC's Motivations And Ranitidine Testing Methods May Not Be Scrutinized Before Trial | 2/24/2022
• Zantac Lawsuits May Go To Trial In California In October Of This Year | 2/18/2022
• Sanofi's History Of Reprehensible Corporate Behavior May Bolster Zantac Cancer Lawsuits | 2/10/2022

Lawyers for Zantac Heartburn Medicine Lawsuits

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.